Risk factors for lung disease progression in children with cystic fibrosis
Eur Respir J
.
2018 Oct 4;52(4):1801492.
doi: 10.1183/13993003.01492-2018.
Print 2018 Oct.
Authors
Hafez Al Momani
1
,
Audrey Perry
2
,
Rhys Jones
3
,
Melissa McDonnell
4
,
Amaran Krishnan
3
,
Andrew Robertson
5
,
Mike Griffin
3
,
Robert Rutherford
4
,
Malcolm Brodlie
6
,
Jeff Pearson
7
,
Steve Bourke
8
,
Chris Ward
9
Affiliations
1
Medical Microbiology, The Hashemite University, Zarqa, Jordan.
2
Dept of Medical Microbiology, The Freeman Hospital, Newcastle upon Tyne Hospitals Trust, Newcastle Upon Tyne, UK.
3
Northern Oesophago-Gastric Unit, Royal Victoria Infirmary, Newcastle Upon Tyne, UK.
4
Respiratory Medicine, Galway University Hospitals, Galway, Ireland.
5
Royal Infirmary of Edinburgh, Edinburgh, UK.
6
Great North Children's Hospital, Paediatric Respiratory Medicine, Institute of Cellular Medicine, Newcastle University, Newcastle Upon Tyne, UK.
7
Institute for Cell and Molecular Bioscience, Newcastle University, Newcastle Upon Tyne, UK.
8
Newcastle Adult Cystic Fibrosis Centre, Royal Victoria Infirmary, Newcastle upon Tyne, UK.
9
Institute for Cellular Medicine, Newcastle University, Newcastle Upon Tyne, UK
[email protected]
.
PMID:
30287494
DOI:
10.1183/13993003.01492-2018
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Child
Cystic Fibrosis*
Disease Progression
Humans
Lung
Risk Factors
Grants and funding
MR/M008797/1/MRC_/Medical Research Council/United Kingdom
MRF_MRF-091-0001-RG-GARNE/MRF/MRF/United Kingdom